ALAS1 and autoimmune pancreatitis: Notably, animal research examining repeated administration of the cannabinoid CB1 receptor agonist CP-55,940 on heme metabolism found that treatment with CP-55,940 actually decreased hepatic activities of ALAS1, which indicates that cannabis may be a candidate for future research as a safe analgesic remedy in AIP [14].